Skip to main content
Thor Medical ASA logo

Thor Medical ASA — Investor Relations & Filings

Ticker · NANOV ISIN · NO0010597883 LEI · 5967007LIEEXZXG6DK30 OL Manufacturing
Open in API
Filings indexed 106 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country NO Norway
Listing OL NANOV

About Thor Medical ASA

https://www.thormedical.com/

Thor Medical ASA is a producer and supplier of alpha-particle emitters for cancer therapy. The company specializes in manufacturing isotopes, such as Thorium-228, by separating decay products from naturally occurring Thorium-232. This is achieved through a proprietary production technology that offers high efficiency, cost-competitiveness, and superior environmental friendliness. The company provides these critical alpha-emitters to partners developing next-generation targeted alpha therapies for precision oncology.

Recent filings

Filing Released Lang Actions
Thor Medical Enters Partnership Agreement with Minerva Imaging to Support Availability of Lead-212 in Europe - Attachment: Download announcement as PDF.pdf
Regulatory Filings Classification · 75% confidence The document is a corporate press release announcing a strategic partnership and supply agreement between Thor Medical and Minerva Imaging. It does not contain financial statements, regulatory form references, management changes, capital transactions, or other specific report content. It is a general corporate announcement, thus best classified under the fallback category for miscellaneous regulatory announcements.
2026-05-29 English
Thor Medical Enters Partnership Agreement with Minerva Imaging to Support Availability of Lead-212 in Europe
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing a partnership and supply agreement between Thor Medical ASA and Minerva Imaging. It contains no financial results, no shareholder votes, no regulatory form references, no proxy materials, and no management changes. It is not a formal financial report or earnings release, but rather a general business announcement. There is no specific form or detailed financial data, so it falls into the fallback category for general regulatory announcements.
2026-05-29 English
Thor Medical Enters Partnership with Eckert & Ziegler to Enable Access of Lead-212 for the Pharmaceutical Industry - Attachment: Download announcement as PDF.pdf
Regulatory Filings Classification · 35% confidence The document is a non-regulatory press release announcing a collaboration agreement between Thor Medical ASA and Eckert & Ziegler. It contains no financial statements, management change notices, earnings data, or regulatory disclosures, and does not fit any specific filing category such as M&A, capital update, or dividend notice. As such, it falls into the miscellaneous/general announcements category, which in our taxonomy corresponds to Regulatory Filings (RNS) as the fallback classification.
2026-05-28 English
Thor Medical Enters Partnership with Eckert & Ziegler to Enable Access of Lead-212 for the Pharmaceutical Industry
Regulatory Filings Classification · 85% confidence The document is a non-regulatory press release announcing a strategic collaboration and supply agreement between Thor Medical and Eckert & Ziegler. It contains no financial statements, no meeting materials, no management or board changes, no share transactions, no regulatory form references, and is not an actual report or transcript. It is a corporate announcement that does not fit other specific filing categories, so it falls into the general Regulatory Filings (RNS) category.
2026-05-28 English
Thor Medical ASA: New share capital registered - Attachment: Download announcement as PDF.pdf
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding the registration of new share capital following a share issuance to board members. It references a previous stock exchange announcement and provides updated share capital and voting rights information. The document is under 5,000 characters and does not contain detailed financial statements or analysis. It is an official notice about a capital change, specifically the registration of new shares and updated share capital. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2026-05-08 Norwegian
Thor Medical ASA: New share capital registered
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement (2130 characters) about the registration of new share capital following a share issuance to board members. It references a previous stock exchange announcement and provides details on the new share capital and voting rights. There are no financial statements or detailed financial data present. The document is primarily an update on a capital change event, specifically the registration of new shares. According to the classification rules, such announcements about new share issues or capital changes fall under the category 'Share Issue/Capital Change' (SHA). The document is not a full report but a brief regulatory announcement about capital changes.
2026-05-08 Norwegian

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.